QA: ACHILLION PHARMACEUTICALS INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001070336_2019_ACHILLION_PHARMACEUTICALS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001070336')"}

Graph

Absolute values for 0001070336, ACHILLION PHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 275,380,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,137,000
3 remainder_Assets 341,000
4 LiabilitiesCurrent 11,829,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 17,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,896,000
9 ResearchAndDevelopmentExpense 50,118,000
10 remainder_Expenses 1,936,000
11 remainder_Revenues 0
12 remainder_NetIncome 5,678,000
13 remainder_ComprehensiveNetIncome 190,000
  yvar yval
0 Assets 277,858,000
1 Liabilities 11,846,000
2 Expenses 75,950,000
3 Revenues 0
4 StockholdersEquity 266,012,000
5 NetIncome -70,272,000
6 ComprehensiveNetIncome -70,177,000
7 BaseVar 185,761,000
8 EconomicCapitalRatio 2.67

Edgar->Model Mapping

Feature Distribution

Change over Time